Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Return to Work After Potential Severe Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02602405
Recruitment Status : Completed
First Posted : November 11, 2015
Last Update Posted : December 21, 2017
Sponsor:
Collaborators:
St. Olavs Hospital
Statistics Norway
Namsos Hospital
Levanger Hospital
Alesund Hospital
Molde Hospital
Kristiansund Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
In Norway an estimated 10 % of the population is injured annually. Of these 36.000 sustain permanent functional impairment, 1.200 receive disability pension, and approximately 2.500 die because of their injuries. Mortality is the most common variable measuring trauma outcome. However, measuring only trauma mortality may be looking merely at the tip of the iceberg. For every trauma death, there are ten-folds suffering long term functional impairment. Mortality is therefore a too crude variable to describe the impact of injuries - both for the individual trauma patient and for society as a whole. There is a need for variables describing long-term outcomes on a functional level. The aim of this study is to use the rate of return to work and education as an alternative outcome measure. The ability of returning to work after injury is a central indicator of individual functional outcome, combining both physical and mental skills in performing complex and compound tasks. Previous studies on return to work after injury are limited by a combination of short follow-up times, the use of patient reported outcomes and having mainly been focusing on only severely injured patients (ISS > 15). This a population-based study including all patients in working age (16 - 65 years) received by a trauma team in any of the eight hospitals within the region of Central Norway in the time period from June 1st,2007 to May 30th, 2010. Already collected trauma registry data will be linked with national register data on sickness and disability benefits, employment and education.

Condition or disease
Multiple Trauma

Layout table for study information
Study Type : Observational
Actual Enrollment : 1741 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Return to Work After Potential Severe Injury; a Population Based Observational Study
Actual Study Start Date : December 2015
Actual Primary Completion Date : August 2016
Actual Study Completion Date : August 2016



Primary Outcome Measures :
  1. Return to work [ Time Frame: up to 8 years ]
  2. Return to education [ Time Frame: up to 8 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years to 65 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients in working age received by a trauma team in any of the eight hospitals within the region of Central Norway in the period from June 1st, 2007 to May 30th, 2010
Criteria

Inclusion Criteria:

  • exposed to traumatic injuries
  • received by trauma team attendance
  • received by trauma team activation protocol

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02602405


Locations
Layout table for location information
Norway
Kristiansund Hospital
Kristiansund, Norway
Levanger Hospital
Levanger, Norway
Molde Hospital
Molde, Norway
Namsos Hospital
Namsos, Norway
Orkanger Hospital
Orkanger, Norway
St Olavs Hospital
Trondheim, Norway
Volda Hospital
Volda, Norway
Ålesund Hospital
Ålesund, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Statistics Norway
Namsos Hospital
Levanger Hospital
Alesund Hospital
Molde Hospital
Kristiansund Hospital
Investigators
Layout table for investigator information
Study Director: Pål Klepstad, md prof Norwegian University of Science and Technology
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT02602405    
Other Study ID Numbers: 2015/1582
First Posted: November 11, 2015    Key Record Dates
Last Update Posted: December 21, 2017
Last Verified: December 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Norwegian University of Science and Technology:
Outcome Assessment (Health Care)
Return to work
Registries
Norway
Additional relevant MeSH terms:
Layout table for MeSH terms
Multiple Trauma
Wounds and Injuries